Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

FDA accepts for review Dupixent sBLA for moderate to severe asthma

March 2, 2018

Genentech and Roche present new TRPA1 antagonists

Feb. 27, 2018

Max-Delbrueck-Centrum, Forschungsverbund Berlin patent novel tryptophan 5-hydroxylase inhibitors

Feb. 23, 2018

Vertex announces phase III study of VX-659, tezacaftor and ivacaftor for cystic fibrosis

Feb. 22, 2018

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery patent PTGDR2 antagonists

Feb. 20, 2018

Novel transgelin-2 agonist reduces asthmatic pulmonary resistance in mice

Feb. 16, 2018

Santhera licenses POL-6014 from Polyphor

Feb. 15, 2018

Vectus Biosystems patents compounds for pulmonary fibrosis

Feb. 15, 2018

Kadmon reports phase II data on KD-025 in IPF

Feb. 13, 2018

FDA approves Symdeko to treat underlying cause of cystic fibrosis

Feb. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...